EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H21F4N5O3 |
| Net Charge | 0 |
| Average Mass | 479.434 |
| Monoisotopic Mass | 479.15805 |
| SMILES | COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn([C@@H](C)C(F)(F)F)c(N)c2C(N)=O)cc1 |
| InChI | InChI=1S/C22H21F4N5O3/c1-11(22(24,25)26)31-19(27)17(20(28)32)18(30-31)13-5-3-12(4-6-13)10-29-21(33)15-9-14(23)7-8-16(15)34-2/h3-9,11H,10,27H2,1-2H3,(H2,28,32)(H,29,33)/t11-/m0/s1 |
| InChIKey | FWZAWAUZXYCBKZ-NSHDSACASA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| pirtobrutinib (CHEBI:229212) has role antineoplastic agent (CHEBI:35610) |
| pirtobrutinib (CHEBI:229212) has role apoptosis inducer (CHEBI:68495) |
| pirtobrutinib (CHEBI:229212) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617) |
| pirtobrutinib (CHEBI:229212) is a benzamides (CHEBI:22702) |
| pirtobrutinib (CHEBI:229212) is a monofluorobenzenes (CHEBI:83575) |
| pirtobrutinib (CHEBI:229212) is a monomethoxybenzene (CHEBI:25235) |
| pirtobrutinib (CHEBI:229212) is a organofluorine compound (CHEBI:37143) |
| pirtobrutinib (CHEBI:229212) is a primary amino compound (CHEBI:50994) |
| pirtobrutinib (CHEBI:229212) is a primary carboxamide (CHEBI:140324) |
| pirtobrutinib (CHEBI:229212) is a pyrazoles (CHEBI:26410) |
| pirtobrutinib (CHEBI:229212) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| 5-amino-3-{4-[(5-fluoro-2-methoxybenzamido)methyl]phenyl}-1-[(2S)-1,1,1-trifluoropropan-2-yl]-1H-pyrazole-4-carboxamide |
| INNs | Source |
|---|---|
| pirtobrutinib | WHO MedNet |
| pirtobrutinibum | WHO MedNet |
| pirtobrutinib | WHO MedNet |
| pirtobrutinib | WHO MedNet |
| Synonyms | Source |
|---|---|
| LOXO-305 | DrugBank |
| LY3527727 | DrugBank |
| LY-3527727 | DrugBank |
| RXC-005 | DrugBank |
| RXC005 | ChEBI |
| LY 3527727 | ChEBI |
| Brand Name | Source |
|---|---|
| Jaypirca | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| DB17472 | DrugBank |
| D12050 | KEGG DRUG |
| Pirtobrutinib | Wikipedia |
| Y7W | PDBeChem |
| 114875989 | ChemSpider |
| Registry Numbers | Sources |
|---|---|
| CAS:2101700-15-4 | KEGG DRUG |
| Citations |
|---|